Nurix Therapeutics, Inc. (NRIX)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 20.74 |
| Open | 20.83 |
| Bid | 20.80 x 400 |
| Ask | 20.91 x 3700 |
| Day's range | 19.76 - 20.94 |
| 52-week range | 4.22 - 22.44 |
| Volume | |
| Avg. volume | 1,198,512 |
| Market cap | 1.274B |
| Beta (5Y monthly) | 2.17 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.66 |
| Earnings date | 11 July 2024 - 15 July 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 25.09 |
ZacksBeyond Air, Inc. (XAIR) Reports Q4 Loss, Misses Revenue Estimates
Beyond Air (XAIR) delivered earnings and revenue surprises of 23.40% and 33.33%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
GuruFocus.comInsider Sale: CFO Houte Van Sells 20,000 Shares of Nurix Therapeutics Inc (NRIX)
On June 20, 2024, Houte Van, Chief Financial Officer of Nurix Therapeutics Inc (NASDAQ:NRIX), executed a sale of 20,000 shares of the company at a price of $20.01 per share. This transaction was documented in an SEC Filing. Following this sale, the insider now owns 48,333 shares of Nurix Therapeutics Inc.
ZacksNurix Therapeutics (NRIX) Surges 20.6%: Is This an Indication of Further Gains?
Nurix Therapeutics (NRIX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
© 2024 Yahoo. All rights reserved.